LYTTON LAURENCE W 13D and 13G filings for DiaMedica Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-02-15 2:25 pm Sale |
2021-12-31 | 13G | DiaMedica Therapeutics Inc. DMAC |
LYTTON LAURENCE W | 1,071,970 4.100% |
-308,296![]() (-22.34%) |
Filing |
2021-10-06 4:19 pm Purchase |
2021-09-26 | 13G | DiaMedica Therapeutics Inc. DMAC |
LYTTON LAURENCE W | 1,380,266 5.200% |
1,380,266![]() (New Position) |
Filing |